ConductScience.org, home

Library / Genes

BLNK: B cell linker

1 protein, 30 patents, 0 drugs, 0 trials, 2,264 NIH grants and 4,823 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolBLNKHGNC
NameB cell linkerHGNC
NCBI Gene ID29760NCBI Gene
HGNC IDHGNC:14211HGNC
EnsemblENSG00000095585NCBI Gene
AliasesAGM4, BASH, BLNK-S, BLNK-s, LY57, Ly57, SLP-65, SLP65, bcaNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q8WV28B-cell linker protein4561Ensembl, GeneID, HGNCUniProt

Patents 30

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1438677Q8WV28Espacenet
JP 2025062604 A2025-04-148480Q8WV28Espacenet
JP 2025032204 A2025-03-1125201Q8WV28Espacenet
EP 4461818 A22024-11-1325201Q8WV28Espacenet
JP 2023058610 A2023-04-2525201Q8WV28Espacenet
US 11446398 B22022-09-208480Q8WV28Espacenet
JP 2022524081 A2022-04-27111451Q8WV28Espacenet
JP 2022512897 A2022-02-0738Q8WV28Espacenet
JP 2022502433 A2022-01-1138Q8WV28Espacenet
JP 2022502435 A2022-01-1138Q8WV28Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2264

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant162,025NIH's project files
P30CA008748Cancer Center Support Grant132,025NIH's project files
R01CA157644Central tolerance mechanisms in B-cell malignancies112,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)92,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award72,025NIH's project files
ZIABC011008Oncogenic mechanisms and molecular targets in lymphoma62,025NIH's project files
R01AI043957Structural Studies of a T cell Specific Tyrosine Kinase52,025NIH's project files
P30CA077598Cancer Center Support Grant42,025NIH's project files
R01HL129061Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD42,025NIH's project files
R15GM131222Probing the Role of Insulin-Like Growth Factor-Binding Protein 3 and Humanin in Regulating Hyaluronan Function42,025NIH's project files

Papers 4823

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42574932PubTator, text miningPubMed
42463013PubTator, text miningPubMed
42388536PubTator, text miningPubMed
42369229PubTator, text miningPubMed
42304605PubTator, text miningPubMed
42287635PubTator, text miningPubMed
42268713PubTator, text miningPubMed
42227173PubTator, text miningPubMed
42170242PubTator, text miningPubMed
42022013PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license